We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+5.19%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$34.1B
AUM Growth
+$362M
Cap. Flow
-$1.11B
Cap. Flow %
-3.25%
Top 10 Hldgs %
15.48%
Holding
3,181
New
192
Increased
947
Reduced
1,799
Closed
170

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$63.9M
2
MSFT icon
Microsoft
MSFT
+$31.4M
3
IBM icon
IBM
IBM
+$23.4M
4
XOM icon
ExxonMobil
XOM
+$23M
5
PFE icon
Pfizer
PFE
+$18.3M

Sector Composition

Rank Sector Weight
1 Financials 14.59%
2 Technology 14.25%
3 Healthcare 13.21%
4 Industrials 11.1%
5 Energy 9.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GTS
2201
DELISTED
Triple-S Management Corporation
GTS
$560K ﹤0.01%
32,852
+262
+0.8% +$4.22K
ERIC icon
2202
Ericsson
ERIC
$32.2B
$558K ﹤0.01%
46,160
MCP
2203
DELISTED
MOLYCORP INC COM STK
MCP
$558K ﹤0.01%
217,005
+41,676
+24% +$151K
DB icon
2204
Deutsche Bank
DB
$69B
$557K ﹤0.01%
17,726
+1,731
+11% +$61.7K
NSM
2205
DELISTED
Nationstar Mortgage Holdings
NSM
$556K ﹤0.01%
15,327
-153
-1% -$5.07K
BHC icon
2206
Bausch Health
BHC
$2.58B
$555K ﹤0.01%
4,400
+300
+7% +$38.3K
DHT icon
2207
DHT Holdings
DHT
$2.99B
$555K ﹤0.01%
+77,125
New +$577K
ANGO icon
2208
AngioDynamics
ANGO
$611M
$554K ﹤0.01%
33,927
-1,460
-4% -$21.1K
NGS icon
2209
Natural Gas Services Group
NGS
$472M
$552K ﹤0.01%
16,693
-520
-3% -$16.1K
PRO
2210
DELISTED
PROS Holdings
PRO
$552K ﹤0.01%
20,891
-432
-2% -$11.2K
PRTA icon
2211
Prothena Corp
PRTA
$425M
$552K ﹤0.01%
24,461
+7,683
+46% +$192K
RMTI icon
2212
Rockwell Medical
RMTI
$28.4M
$552K ﹤0.01%
419
+8
+2% +$9.62K
TNGO
2213
DELISTED
Tangoe, Inc.
TNGO
$551K ﹤0.01%
36,579
+3,953
+12% +$61.2K
WLT
2214
DELISTED
WALTER ENERGY INC COM STK (DE)
WLT
$551K ﹤0.01%
101,099
+5,290
+6% +$33.6K
VLCCF
2215
DELISTED
KNIGHTSBRIDGE TANKERS LTD
VLCCF
$551K ﹤0.01%
38,864
+5,057
+15% +$71.7K
MDXG icon
2216
MiMedx Group
MDXG
$602M
$550K ﹤0.01%
77,588
+2,575
+3% +$15.1K
AGIO icon
2217
Agios Pharmaceuticals
AGIO
$1.79B
$549K ﹤0.01%
+11,990
New +$489K
ARAY icon
2218
Accuray
ARAY
$32M
$549K ﹤0.01%
62,396
-3,237
-5% -$28K
ITUB icon
2219
Itaú Unibanco
ITUB
$93.2B
$547K ﹤0.01%
94,882
+3,567
+4% +$21K
AMAG
2220
DELISTED
AMAG Pharmaceuticals
AMAG
$547K ﹤0.01%
26,389
+2,749
+12% +$50.8K
ATSG
2221
DELISTED
Air Transport Services Group
ATSG
$546K ﹤0.01%
65,287
-2,012
-3% -$17K
MFRM
2222
DELISTED
MATTRESS FIRM HLDG CORP COM STK (DE)
MFRM
$546K ﹤0.01%
11,427
+534
+5% +$24.7K
RTK
2223
DELISTED
Rentech, Inc.
RTK
$545K ﹤0.01%
21,025
-1,205
-5% -$26.8K
DENN
2224
DELISTED
Denny's
DENN
$544K ﹤0.01%
83,400
-5,830
-7% -$38K
CS
2225
DELISTED
Credit Suisse Group
CS
$544K ﹤0.01%
19,185
+1,100
+6% +$33.7K

Similar funds

RhumbLine Advisers's Q2 2014 Portfolio in Review

As of Q2 2014, RhumbLine Advisers held 3,181 positions worth $34.1B, up 1.1% from $33.7B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

RhumbLine Advisers withdrew a net $1.11B in Q2 2014, closing 170 positions and reducing 1,799 holdings. Its most notable exit was BEAM INC COM STK (DE), an estimated $18.3M position sold in full.

By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 15% a quarter earlier, followed by Technology and Healthcare.

Against the trend, RhumbLine Advisers opened a new position in Navient worth $10M.

  • RhumbLine Advisers's largest Q2 2014 buy was Navient: 566,289 shares worth $10M.
  • RhumbLine Advisers added most to American Airlines Group in Q2 2014, an estimated $22.1M increase.
  • RhumbLine Advisers's biggest Q2 2014 reduction was Apple, cutting an estimated $63.9M.
  • RhumbLine Advisers fully exited BEAM INC COM STK (DE) in Q2 2014, selling an estimated $18.3M.
  • RhumbLine Advisers's ten largest holdings make up 15% of its $34.1B portfolio in Q2 2014.
  • RhumbLine Advisers opened 192 new positions and closed 170 in Q2 2014.
  • RhumbLine Advisers's portfolio value rose 1.1% quarter-over-quarter to $34.1B.

Based on RhumbLine Advisers's 13F filing for Q2 2014, filed 6 Aug 2014.